These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1994457)

  • 1. Long-term complications of cardiac transplantation.
    Miller LW
    Prog Cardiovasc Dis; 1991; 33(4):229-82. PubMed ID: 1994457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical problems in heart transplant recipients].
    Magelli C; Magnani G; Grigioni F; Coccolo F; Potena L; Leone O; Magnani B
    Ital Heart J Suppl; 2003 Apr; 4(4):277-98. PubMed ID: 12784764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up after cardiac transplantation.
    Parameshwar J
    Br J Hosp Med; 1996 Oct 2-15; 56(7):350-4. PubMed ID: 8899224
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytokine profiles as marker for graft vascular disease after clinical heart transplantation.
    van Besouw NM; Baan CC; Holweg CT; de Groot-Kruseman HA; Peeters AM; Balk AH; Weimar W
    Ann Transplant; 2000; 5(2):61-7. PubMed ID: 11217209
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug treatment of clinical problems related to cardiac transplantation.
    Hankins S; Mancini D
    Heart Dis; 2002; 4(4):242-51. PubMed ID: 12147184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppression after heart and lung transplantation].
    Wendler O; Schäfers HJ
    Med Klin (Munich); 1997 Dec; 92 Suppl 5():3-7. PubMed ID: 19479389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclosporine A monotherapy on the incidence of rejection and infection episodes in heart transplant patients.
    Seydoux C; Stumpe F; Hurni M; Ruchat P; Fischer A; Mueller X; von Segesser L; Goy JJ
    Transplant Proc; 1998 Dec; 30(8):4037-43. PubMed ID: 9865288
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term results of combined heart and kidney transplantation: a French multicenter study.
    Vermes E; Grimbert P; Sebbag L; Barrou B; Pouteil-Noble C; Pavie A; Obadia JF; Loisance D; Lang P; Kirsch M
    J Heart Lung Transplant; 2009 May; 28(5):440-5. PubMed ID: 19416771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term medical complications of heart transplantation: information for the primary care physician.
    Yamani MH; Starling RC
    Cleve Clin J Med; 2000 Sep; 67(9):673-80. PubMed ID: 10992625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
    Pham SM; Kormos RL; Kawai A; Murali S; Hattler BG; Demetris AJ; Griffith BP
    Transplant Proc; 1996 Apr; 28(2):1002-4. PubMed ID: 8623208
    [No Abstract]   [Full Text] [Related]  

  • 11. A Case of Hidroacanthoma Simplex in a Cardiac Transplant Recipient.
    Panagou E; Ellery P; Martyn-Simmons C; Perrett CM
    Transplantation; 2020 Mar; 104(3):e77-e78. PubMed ID: 31577672
    [No Abstract]   [Full Text] [Related]  

  • 12. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry.
    Brann WM; Bennett LE; Keck BM; Hosenpud JD
    J Heart Lung Transplant; 1998 Apr; 17(4):374-82. PubMed ID: 9588582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Rapping' up cardiac allograft vasculopathy.
    Khalpey Z; Kushwaha SS
    Clin Cardiol; 2008 Jun; 31(6):286-7. PubMed ID: 17803252
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for the development and progression of dyslipidemia after heart transplantation.
    Akhlaghi F; Jackson CH; Parameshwar J; Sharples LD; Trull AK
    Transplantation; 2002 Apr; 73(8):1258-64. PubMed ID: 11981418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation.
    Hisatomi K; Isomura T; Matsuzoe S; Satou T; Hirano A; Kohjiro M
    Transplant Proc; 1996 Jun; 28(3):1958-60. PubMed ID: 8658960
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival after heart transplantation without regular immunosuppression.
    Ruygrok PN; Agnew TM; Coverdale HA; Whitfield C; Lambie NK
    J Heart Lung Transplant; 1994; 13(2):208-11. PubMed ID: 8031801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppression after heart transplantation. Results of a study of 2 therapeutic protocols].
    Faggian G; Livi U; Chiominto B; Michielon G; Angelini A; Bortolotti U; Mazzucco A; Thiene G; Gallucci V
    G Ital Cardiol; 1989 Dec; 19(12):1141-3. PubMed ID: 2634570
    [No Abstract]   [Full Text] [Related]  

  • 18. Antithymocyte globulin induction therapy in heart transplantation: prospective randomized study of high vs standard dosage.
    Faggian G; Forni A; Milano AD; Chiominto B; Walpoth BH; Scarabelli T; Mazzucco A
    Transplant Proc; 2010 Nov; 42(9):3679-87. PubMed ID: 21094838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of the cardiac transplant recipient: roles of the transplant cardiologist and primary care physician.
    Wagoner LE
    Am J Med Sci; 1997 Sep; 314(3):173-84. PubMed ID: 9298043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?
    Groetzner J; Meiser BM; Schirmer J; Koglin J; vScheidt W; Klauss V; Cremer P; Reichenspurner H; Reichart B
    Transplant Proc; 2001; 33(1-2):1461-4. PubMed ID: 11267373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.